Pure Global AI
NCT06382818Not yet recruiting

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

Institut du Cancer de Montpellier - Val d'AurelleClinicalTrials.govradiation
Verified
Study focus
Disease/Condition
Breast Cancer
Drug/Device/Intervention
COHORT A
Study type
Interventional
Intervention type
radiation
Sponsor & location
Primary sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Location
Montpellier, France
Timeline & enrollment
Phase
N/A
Start date
Apr 26, 2024
End date
Apr 26, 2036
Enrollment
854 participants
Primary outcome

Rate of patients without any grade 2 or more fibrosis, nor radio-induced sarcoma

Summary

Our objective is based on a personalized approach of adjuvant breast radiotherapy by
 selecting patients according to tumor recurrence and toxicity risk.

ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastCarcinoma in situ of breast, unspecifiedMalignant neoplasm: Breast, unspecifiedOther carcinoma in situ of breast
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06382818
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06382818 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut du Cancer de Montpellier - Val d'Aurelle and is currently Not yet recruiting. The study focuses on Breast Cancer. Target enrollment is 854 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.